Skip to content
10-K

Annual Report

BIOSYNERGY INC

0001437749-21-017834

← back to feed
Filed
Jul 29, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Apr 30, 2021 14.94M sh
Operating Cash Flow FY 2021 · Apr 30, 2021 −$4.2K
Operating Cash Flow FY 2021 · Apr 30, 2020 $71.28K
Stockholders Equity FY 2021 · Apr 30, 2021 $1.74M
Stockholders Equity FY 2021 · Apr 30, 2020 $1.72M
Current Liabilities FY 2021 · Apr 30, 2021 $127.53K
Current Liabilities FY 2021 · Apr 30, 2020 $166.79K
Current Assets FY 2021 · Apr 30, 2021 $1.69M
Current Assets FY 2021 · Apr 30, 2020 $1.7M
Total Assets FY 2021 · Apr 30, 2021 $1.89M
Total Assets FY 2021 · Apr 30, 2020 $2.01M
Sga Expense FY 2021 · Apr 30, 2021 $394.92K
Sga Expense FY 2021 · Apr 30, 2020 $402.26K
Rd Expense FY 2021 · Apr 30, 2021 $157.92K
Rd Expense FY 2021 · Apr 30, 2020 $164.36K
Net Income FY 2021 · Apr 30, 2021 $15.8K
Net Income FY 2021 · Apr 30, 2020 $36.05K
Operating Income FY 2021 · Apr 30, 2021 $17.46K
Operating Income FY 2021 · Apr 30, 2020 $49.47K
Gross Profit FY 2021 · Apr 30, 2021 $739.16K
Gross Profit FY 2021 · Apr 30, 2020 $797.86K
Cost Of Revenue FY 2021 · Apr 30, 2021 $433.98K
Cost Of Revenue FY 2021 · Apr 30, 2020 $439.53K